Vernal Biosciences
PrivateLast Round
VC Round
Jun 27, 2023
Momentum Score
25 /100
Company Overview
Vernal Biosciences is a biotechnology company specializing in high-purity mRNA and LNP-mRNA manufacturing for research and clinical applications, catering to the diverse needs of life science professionals.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vernal Biosciences Comps
Public and private peers based on sector, stage, and business model.
Vernal Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 27, 2023 | ||||
| VC Round | Jun 2, 2022 | ||||
| Seed | Jul 12, 2021 |
Key People
Founding team and executive leadership
Vernal Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dynamk Capital | VC Round |
| Ampersand Capital | VC Round |
| Vermont Center for Emerging Technologies | Seed, VC Round |
Vernal Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vernal Biosciences's valuation, stock price, and market status.
